1-3 of 3
Hsin-Hui Huang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment with First-Line Ibrutinib Improves Overall Survival in Patients with Chronic Lymphocytic Leukemia (CLL) and High-Risk Genomic Features to Rates Approximating an Age-Matched US Population: Pooled Analysis of Phase 3 Trials with 10 Years of Follow-up

Jan A. Burger, Neil E. Kay, John N. Allan, Paul M Barr, Jacqueline C. Barrientos, Carolyn Owen, Victoria Wang, Hsin-Hui Huang, Lynne Neumayr, Christopher Abbazio, Gabriel S. Krigsfeld, Sneh Mody, Paolo Ghia, Tait D. Shanafelt
Journal: Blood
Blood (2024) 144 (Supplement 1): 4615.
https://doi.org/10.1182/blood-2024-194382
Published: 2024
Journal Articles

Single-Agent Ibrutinib Versus Allogeneic Hematopoietic Cell Transplantation for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and del(17p)

Farrukh T. Awan, Ran Liu, Hsin-Hui Huang, Matthew Bye, Kwang Wooahn, Gabriel S. Krigsfeld, Anat Raz, Heather R Wolfe, Mehdi Hamadani
Journal: Blood
Blood (2024) 144 (Supplement 1): 2178.
https://doi.org/10.1182/blood-2024-194156
Published: 2024
Journal Articles

Immune Landscape Associated with Response to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Relapsed/Refractory Hodgkin Lymphoma (E4412 Phase 1)

Catherine S Diefenbach, Edgar Gonzalez-Kozlova, Diane Marie Del Valle, Hsin-Hui Huang, Opeyemi Jegede, Vanessa Barcessat, Kevin Tuballes, Geoffrey Kelly, Manishkumar Patel, Hui Xie, Jocelyn Harris, Kimberly Argueta, Kai Nie, Radim Moravec, Jennifer Altreuter, Dzifa Yawa Duose, Brad S. Kahl, Stephen M Ansell, Joyce Yu, Ethan Cerami, James Lindsay, Ignacio Wistuba, Seunghee Kim-Schulze, Sacha Gnjatic
Journal: Blood
Blood (2023) 142 (Supplement 1): 4382.
https://doi.org/10.1182/blood-2023-174903
Published: 2023